Dr. Raymond Tjandrawinata: Pandemic, Maintaining the Innovation Momentum

<p>Dr. Raymond Tjandrawinata, executive director at Dexa Laboratories of Biomolecular Sciences (DLBS), talks about collective conscience, co-evolving with pathogens, and the first monoclonal antibody therapy in Indonesia—a breakthrough treatment for patients with preexisting comorbidities and elderlies.</p> <p>In collaboration with PT Dexa Medica.</p>